Biomedical Engineering Reference
In-Depth Information
[164] Ashurst S , Malton A , Prime D , Pstt BS . Latest advances in the development of dry pow-
der inhalers . Pharm Sci Technol Today 2000 ; 3 : 246 - 56 .
[165] Geller DE . Comparing clinical features of the nebulizer, metered-dose inhaler, and dry
powder inhaler . Respir Care 2005 ; 50 : 1313 - 22 .
[166] Newman SP , Busse WW . Evolution of dry powder inhaler design, formulation, and per-
formance . Am J Respir Crit Care Med 2002 ; 96 : 293 - 304 .
[167] Vidgren MT , Vidgren PA , Paronen TP . Comparison of physical and inhalation proper-
ties of spray dried and mechanically micronized disodium cromoglycate . Int J Pharm
1987 ; 35 : 139 - 44 .
[168] Chan HK , Clark A , Gonda I , Mumenthaler M , Hsu C .
Spray dried powders and powder
blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery . Pharm
Res 1997 ; 14 : 431 - 97 .
[169] Clark AR , Dasovich N , Gonda I , Chan HK . The balance between biochemical and phys-
ical stability for inhalation protein powders: RhDNase as an example . In: Dalby RN ,
Byron PR , Farr SJ , editors. Respiratory drug delivery V . Buffalo Grove. IL : Interpharm
Press ; 1996 . p. 167 - 74 .
[170] Byron PR . Aerosol formulation, generation, and delivery using nonmetered system .
In: Byron PR , editor. Respiratory drug delivery . Boca Raton, FL : CRC Press ; 1990 .
p. 143 - 65 .
[171] Hinds WC. Aerosol technology: properties, behavior, and measurement of airborne par-
ticles . New York, NY : John Wiley and Sons ; 1982 .
[172] O ' Riordan
TG ,
Palmer
LB ,
Smaldone
GC .
Aerosol
deposition
in
mechanically
ventilated
patients:
optimizing
nebulizer
delivery .
Am
J
Respir
Crit
Care
Med
1994 ; 149 : 214 - 19 .
[173] Hindle M , Byron PR . Dose emissions from marketed dry powdered inhalers . Int J
Pharm 1999 ; 116 : 169 - 77 .
[174] Pontiroli AE . Peptide hormones: review of current and emerging uses by nasal delivery .
Adv Drug Deliv Rev 1998 ; 29 : 81 - 7 .
[175] Kern W , Schiefer B , Schwarzenburg J , Stange EF , Born J , Fehm
HL . Evidence for cen-
tral nervous effects of corticotrophin-releasing hormone on gastric acid secretion in
humans . Neuroendocrinology 1997 ; 65 : 291 - 8 .
[176] Smolnik R , Molle M , Fehm HL , Born J .
Brain potentials and attention after acute and
subchronic intranasal administration of ACTH 4-10 and Desacetyl MSH in humans .
Neuroendocrinology 1999 ; 70 : 63 - 72 .
[177] Mayer K, Bridge P, Moon M, Linde R, Roffman M. Phase I study of intranasal peptide
T: clinical and lab results. International Conference on AIDS; 1990 Jun 20- 23, 6, 200.
[178] Vajdy M , O ' Hagan DT . Microparticles for intranasal immunization . Adv Drug Deliv
Rev 2001 ; 51 : 127 - 41 .
[179] Oh YK , Kim JP , Hwang TS , Ko JJ , Kim JJ , Yang JS . Nasal absorption and biodis-
tribution of plasmid DNA: an alternative route of DNA vaccine delivery . Vaccine
2001 ; 19 : 4519 - 25 .
[180] Hruz P , Stefanie Z , Daniela Z , Victor H , Guido AS , Klaus S
, et al . Intranasal admin-
istration of delta sleep-inducing peptide increases P300 . J Clin Psychopharmacol
2001 ; 21 : 626 - 8 .
[181] Mitragotri S . Immunization without needles . Nat Rev Immunol 2005 ; 5 : 905 - 16 .
[182] Slutter B , Hagenaars N , Jiskoot W . Rational design of nasal vaccines
. J Drug Targeting
2008 ; 16 : 1 - 17 .
[183] Burckart GJ , Dowling R , Zenati M , Yousem SA , Venkataramanan R , Griffith BP .
Cyclosporine administration by aerosol . J Clin Pharmacol 1989 ; 29 : 860 .
Search WWH ::
Custom Search